login
  Password reminder
Cardiac Rhythm News
Contact the editor Visit Cardiac Rhythm News Twitter feed Visit Cardiac Rhythm News Facebook page
 

One in 1,000 risk of death from catheter ablation for AF


Tuesday, 05 May 2009 14:23

One in every 1,000 catheter ablations of atrial fibrillation results in the death of the patient, according to a study published in the 12 May 2009 issue of the Journal of the American College of Cardiology.


The authors of the article "Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation" wrote that "knowledge of possible precipitating causes is key to operators and needs to be considered during decision making with patients."


The purpose of the study, led by Dr Ricardo Cappato, Arrhythmia and Electrophysiology Center, Policlinico San Donato, Milan, Italy, was to provide a systematic multicentre survey on the incidence and causes of death occurring in the setting of or as a consequence of catheter ablation of atrial fibrillation.


Using a retrospective case series, data relevant to the incidence and cause of intra- and post-procedural death occurring in patients undergoing ablation of atrial fibrillation between 1995 and 2006 were collected from 162 of 546 identified centres worldwide.


Thirty-two deaths (.98 per 1,000 patients) were reported during 45,115 procedures in 32,569 patients. Causes of deaths included tamponade in eight patients (one later than 30 days), stroke in five patients (two later than 30 days), atrioesophageal fistula in five patients, and massive pneumonia in two patients. Myocardial infarction, intractable torsades de pointes, septicemia, sudden respiratory arrest, extrapericardial pulmonary vein perforation, occlusion of both lateral pulmonary veins, hemothorax, and anaphylaxis were reported to be responsible for one death each, while asphyxia from tracheal compression secondary to subclavian hematoma, intracranial bleeding, acute respiratory distress syndrome, and esophageal perforation from an intraoperative transesophageal echocardiographic probe were causes of one late death each.




Add New Comment

Most popular


Medtronic completes acquisition of Covidien
Tuesday, 27 Jan 2015
Under the terms of the acquisition agreement, Medtronic Inc and Covidien plc are now combined under Medtronic plc. Medtronic completes acquisition of Covidien

Bridging during anticoagulation interruption associated with higher bleeding risk in AF patients
Friday, 30 Jan 2015
A subanalysis from the ORBIT-AF registry has found that atrial fibrillation patients who receive bridging anticoagulation therapy during anticoagulation interruption are at higher risk of bleeding ... Bridging during anticoagulation interruption associated with higher bleeding risk in AF patients

Sorin announces enrolment of first patients in the Vanguard clinical study
Thursday, 12 Feb 2015
The Vanguard (Vagal nerve stimulation safeguarding heart failure patients) clinical study evaluates Equilia, a neurostimulation system for heart failure patients. Sorin announces enrolment of first patients in the Vanguard clinical study

Features


ENSURE-AF: Largest trial ever to explore novel oral anticoagulation in AF patients undergoing cardioversion
Tuesday, 10 Feb 2015
Andreas Goette explains the rationale and details of the ENSURE-AF trial, the largest prospective study evaluating the efficacy and safety of edoxaban (Daiichi Sankyo) compared with enoxaparin/... ENSURE-AF: Largest trial ever to explore novel oral anticoagulation in AF patients undergoing cardioversion

Get With The Guidelines-AFIB: A US quality improvement programme for atrial fibrillation patients
Tuesday, 27 Jan 2015
Guideline adherence to anticoagulation in atrial fibrillation seems to be more difficult compared to other quality measures in cardiology practice. William Lewis explains how the Get With The G... Get With The Guidelines-AFIB: A US quality improvement programme for atrial fibrillation patients

Profiles


Hung-Fat Tse
Tuesday, 03 Feb 2015
While Hung-Fat Tse’s initial research interests focused on device therapy for cardiac arrhythmias, ... Hung-Fat Tse

Massimo Santini
Friday, 10 Oct 2014
Massimo Santini performed the first fulguration of the atrioventricular node of resistant ... Massimo Santini

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions